BE1003466A3 - Compositions pharmaceutiques contenant des pyranoquinoleines. - Google Patents

Compositions pharmaceutiques contenant des pyranoquinoleines. Download PDF

Info

Publication number
BE1003466A3
BE1003466A3 BE9000682A BE9000682A BE1003466A3 BE 1003466 A3 BE1003466 A3 BE 1003466A3 BE 9000682 A BE9000682 A BE 9000682A BE 9000682 A BE9000682 A BE 9000682A BE 1003466 A3 BE1003466 A3 BE 1003466A3
Authority
BE
Belgium
Prior art keywords
pyranoquinoleins
pharmaceutical compositions
compositions containing
allergic
proctile
Prior art date
Application number
BE9000682A
Other languages
English (en)
Original Assignee
Fisons Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB868630769A external-priority patent/GB8630769D0/en
Priority claimed from GB868630767A external-priority patent/GB8630767D0/en
Priority claimed from GB868630904A external-priority patent/GB8630904D0/en
Priority claimed from GB878706684A external-priority patent/GB8706684D0/en
Application filed by Fisons Plc filed Critical Fisons Plc
Application granted granted Critical
Publication of BE1003466A3 publication Critical patent/BE1003466A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)

Abstract

Utilisation de l'acide 9-éthyl-6.9-dihydro-4,6-dioxo-10-propyl-4H-pyrano(3,2-g)quinoléine-2,8-carboxylique ou d'un sel pharmaceutiquement acceptable de celui-ci en solution aqueuse contre la conjonctivité, la kératite, ''l'oeil allergique'', les infections par adénovirus, le rejet de l'homogreffe de cornée, l'uvéïte antérieure, les polypes nasaux, la rhinite vasomotrice, les manifestations allergiques du nasopharynx, l'obstruction réversible des voies respiratoires, la maladie de Crohn, la colite distale ou la proctile.
BE9000682A 1986-12-23 1990-07-04 Compositions pharmaceutiques contenant des pyranoquinoleines. BE1003466A3 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB868630769A GB8630769D0 (en) 1986-12-23 1986-12-23 Pharmaceutical formulation
GB868630767A GB8630767D0 (en) 1986-12-23 1986-12-23 Pharmaceutical formulation
GB868630904A GB8630904D0 (en) 1986-12-24 1986-12-24 Pharmaceutical formulation
GB878706684A GB8706684D0 (en) 1987-03-20 1987-03-20 Pharmaceutical formulation

Publications (1)

Publication Number Publication Date
BE1003466A3 true BE1003466A3 (fr) 1992-03-31

Family

ID=27449862

Family Applications (2)

Application Number Title Priority Date Filing Date
BE8701471A BE1002179A5 (fr) 1986-12-23 1987-12-22 Compositions pharmaceutiques contenant des pyranoquinoleines.
BE9000682A BE1003466A3 (fr) 1986-12-23 1990-07-04 Compositions pharmaceutiques contenant des pyranoquinoleines.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
BE8701471A BE1002179A5 (fr) 1986-12-23 1987-12-22 Compositions pharmaceutiques contenant des pyranoquinoleines.

Country Status (22)

Country Link
US (1) US5443833A (fr)
EP (1) EP0279121B1 (fr)
JP (2) JP2568233B2 (fr)
KR (1) KR960001370B1 (fr)
AU (1) AU595969B2 (fr)
BE (2) BE1002179A5 (fr)
CA (1) CA1296635C (fr)
CH (1) CH674937A5 (fr)
DE (1) DE3787274T2 (fr)
DK (1) DK175032B1 (fr)
ES (1) ES2058129T3 (fr)
FI (1) FI875616A7 (fr)
FR (1) FR2609392B1 (fr)
GR (1) GR871999B (fr)
IE (3) IE63213B1 (fr)
IL (1) IL84893A (fr)
LU (1) LU87087A1 (fr)
MY (1) MY101535A (fr)
NO (1) NO875359L (fr)
NZ (1) NZ223026A (fr)
PT (1) PT86455B (fr)
SA (1) SA90110074B1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8704773D0 (en) * 1987-02-28 1987-04-01 Fisons Plc Compounds
EP0294914A3 (fr) * 1987-03-17 1990-10-10 FISONS plc Nédocromil pour le traitement des maladies dermatologiques
GB8727590D0 (en) * 1987-11-25 1987-12-31 Fisons Plc Formulation
US5976573A (en) 1996-07-03 1999-11-02 Rorer Pharmaceutical Products Inc. Aqueous-based pharmaceutical composition
US7977376B2 (en) 2001-06-27 2011-07-12 Novartis Ag Olopatadine formulations for topical nasal administration
CN102711463B (zh) * 2009-12-03 2015-05-13 Opko健康公司 超硫酸化双糖制剂

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL54614A (en) * 1977-05-04 1983-07-31 Fisons Ltd Dihydrodioxo-pyranoquinoline dicarboxylic acid derivatives,their production and pharmaceutical compositions containing them
ZA782473B (en) * 1977-05-04 1979-04-25 Fisons Ltd Benzo pyrano-quinolinones
US4474787A (en) * 1977-05-04 1984-10-02 Fisons Limited 7,6 Dioxo-4H,6H-pyrano[3,2-g]quinoline dicarboxylic acids and anti-allergic use thereof
FR2440371A1 (fr) * 1978-10-31 1980-05-30 Fisons Ltd Nouveaux composes azotes heterocycliques, des compositions pharmaceutiques en contenant et des procedes pour les preparer
ATE11774T1 (de) * 1979-12-07 1985-02-15 Fisons Plc Verfahren zur herstellung von 1,4-dihydro-4-oxo- chinolin-2-carbonsaeuren oder salzen, estern oder amiden davon und zwischenverbindungen dafuer.
AU8468782A (en) * 1981-06-25 1983-01-06 Fisons Plc Compounds with sodium cromoglycate activity
GB8402047D0 (en) * 1984-01-26 1984-02-29 Fisons Plc Nitrogen heterocycles
EP0162556B1 (fr) * 1984-04-13 1991-11-06 FISONS plc Formes et formulations des sels de sodium de nédocromil
GB8630419D0 (en) * 1986-12-19 1987-01-28 Fisons Plc Pharmaceutical formulation
GB8704089D0 (en) * 1987-02-21 1987-03-25 Fisons Plc Method of treatment
GB8704773D0 (en) * 1987-02-28 1987-04-01 Fisons Plc Compounds
EP0294914A3 (fr) * 1987-03-17 1990-10-10 FISONS plc Nédocromil pour le traitement des maladies dermatologiques

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
BR. J. CLIN. PHARMAC., vol. 24, October 1987, pages 493-501; M.G. NEALE et al.: "The pharmacokinetics of nedrocromil sodium, a new drug for the treatment of reversible obstructive airways disease, in human volunteers and patients with reversible obstructive airways disease" *
EUR. J. RESPIR. DIS., vol. 69, suppl. 147, 1986, pages 120-131; R.M. AUTY: "The clinical development of a new agent for the treatment of airway inflammation, nedocromil sodium (Tilade)" *
INVEST OPHTALMOL VISUAL SCI., vol. 29, 1-6 mai 1988, page 229; A. STOCKWELL et al.: "Double blind group comparative trial of 2% nedrocromil sodium eye drops with placebo eye drops in the treatment of seasonal allergic conjunctivitis" *
J. ALLERGY CLIN. IMMUNO., vol. 80, no. 2, août 1987, pages 218-222; O.J. CORRADO et al.: "The effect of nedocromil sodium on nasal provocation with allergen" *
J. ALLERGY CLIN. IMMUNOL., vol. 79, no. 1, 19-25 février 1987, page 186, abrégé 247: H.J. SCHWARTZ et al.: "Efficacy of hedrocromil sodium (MS) 1% nasal solution in the treatment of ragweed seasonal allergic rhimitis (SAR)" *
J. ALLERGY CLIN. IMMUNOL., vol. 81, no. 3, mars 1988, pages 570-574; J. RUHNO et al.: "Intranasal nedocromil sodium in the treatment of ragweed-allergic rhinitis" *
P.H. LIST: "Arzneiformenlehre", 1976, pages 369-373,400-410, Wissenschaftliche Verlagsgesellschaft mbH, Stuttgart, DE *

Also Published As

Publication number Publication date
MY101535A (en) 1991-11-30
JP2504926B2 (ja) 1996-06-05
EP0279121A2 (fr) 1988-08-24
FI875616L (fi) 1988-06-24
PT86455B (pt) 1990-11-20
DE3787274T2 (de) 1994-01-27
JPS63233918A (ja) 1988-09-29
IL84893A (en) 1991-11-21
JP2568233B2 (ja) 1996-12-25
NZ223026A (en) 1989-09-27
IE940371L (en) 1988-06-23
GR871999B (en) 1988-04-26
IE940372L (en) 1988-06-23
EP0279121B1 (fr) 1993-09-01
JPH07231926A (ja) 1995-09-05
SA90110074B1 (ar) 2006-03-06
CA1296635C (fr) 1992-03-03
DK175032B1 (da) 2004-05-03
KR880007082A (ko) 1988-08-26
FI875616A7 (fi) 1988-06-24
EP0279121A3 (en) 1990-09-12
FR2609392A1 (fr) 1988-07-15
ES2058129T3 (es) 1994-11-01
DK680787D0 (da) 1987-12-22
LU87087A1 (fr) 1989-07-07
BE1002179A5 (fr) 1990-10-02
IE873507L (en) 1988-06-23
PT86455A (en) 1988-01-01
DE3787274D1 (de) 1993-10-07
IE63213B1 (en) 1995-04-05
AU595969B2 (en) 1990-04-12
NO875359L (no) 1988-06-24
DK680787A (da) 1988-06-24
FI875616A0 (fi) 1987-12-21
IL84893A0 (en) 1988-06-30
US5443833A (en) 1995-08-22
AU8292987A (en) 1988-06-23
NO875359D0 (no) 1987-12-21
FR2609392B1 (fr) 1994-04-08
KR960001370B1 (ko) 1996-01-26
CH674937A5 (fr) 1990-08-15

Similar Documents

Publication Publication Date Title
TWI291350B (en) Pharmaceutical composition for ophthalmic use
KR890011823A (ko) 벤조일 페닐아세트산 유도체 약제 조성물
NO166448C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolidindioner.
DK275488D0 (da) Indolonderivater
GR3014937T3 (en) Aqueous opthalmic solutions for the treatment of dryness and/or irritation of human or animal eyes.
DK8885D0 (da) N-heterocyclyl-4-piperidinaminderivater og fremgangsmaade til fremstilling deraf
NO176346C (no) Fremgangsmåte ved fremstilling av en flytende, vandig farmasöytisk blanding for öye- og/eller nasal administrasjon
DK213087A (da) 1,4-disubstituerede piperazinderivater og farmaceutisk acceptable syreadditionssalte deraf, deres fremstilling og anvendelse
RU98119956A (ru) Раствор для хранения роговицы, включающий гиалуроновую кислоту, способ хранения ткани роговицы и применение раствора для хранения тканей роговицы
BE1003466A3 (fr) Compositions pharmaceutiques contenant des pyranoquinoleines.
CA2005987A1 (fr) Benzimidazole substitue ayant une action therapeutique et procede de preparation
JPH0358935A (ja) ヒアルロン酸塩の安定な平衡塩媒体溶液
NO975094L (no) Vinylpyrrolidoncefalosporinderivater
EP0337136A3 (fr) Dérivés du pipéridine dans le traitement des effets secondaires de la thérapie neuroleptique
RU2001118854A (ru) Оптически активное производное пиридил-4н-1,2,4-оксадиазина и его применение при лечении сосудистых заболеваний
ATE55248T1 (de) Arzneimittelkombination.
CA2245197A1 (fr) Derives insatures en position -4 du 6-tert-butyl-1,1-dimethylindane et leur utilisation en medecine humaine ou veterinaire ainsi qu'en cosmetique
NO814138L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n-pyrimidyl-karbaminsyreestere
FR2661091B1 (fr) Utilisation de l'hexetidine ou de ses derives ou sels pour la preparation d'une composition pharmaceutique a usage ophtalmologique.
NO158676C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-furyl-3,4-dihydroisokinolin-derivater.
KR960014874B1 (ko) 요산 배출용 조성물
KR970032865A (ko) 허혈성 심질환으로 고생하는 환자의 경색크기를 감소하기 위한 방법
IT1226637B (it) Composizioni farmaceutiche a base di nedocromil sodio, metodi per la loro preparazione, e loro uso
GB899037A (en) Benzothiadiazine compounds
BE904737A (fr) Derives de l'acide octenoique.

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: *FISONS P.L.C.

Effective date: 20071222